The psychedelic DMT has been linked to improved mental health outcomes before, but now, scientists have shown it reduces ...

Feb 17 (Reuters) - Drug developer Compass Pathways said on Tuesday its psilocybin-based depression therapy reduced the severity of symptoms in a late-stage study, sending its shares up nearly 30%. The ...

San Juan Capistrano, California / Syndication Cloud / February 12, 2026 / Mission Prep Key Takeaways Teen depression ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the ...

The idea that depression is caused by a chemical imbalance in the brain is more than half a century old. The reality is more ...

A psychedelic compound found in the Amazonian hallucinogenic brew ayahuasca quickly curbed clinical depression sufferers’ ...

Late-onset depression may be an early sign of Parkinson’s disease (PD) or Lewy Body dementia (LBD), according to a December study published in General Psychiatry.

People taking DMT tended to experience significant relief from their depression for up to three months, the researchers found ...

Wearable trackers could even detect the probability of a relapse weeks or months before it occurs. Up to around 60% of people ...

Depression in older adults may sometimes signal the early stages of Parkinson’s disease or Lewy body dementia. Researchers found that depression often appears years before diagnosis and remains ...

People with brain disorders, including Parkinson's disease and dementia, are often misdiagnosed as having depression, when in ...

By Tarun Sai Lomte A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation and the need for larger ...